Phosphonorm, Hartkapseln

7680458660174 CH-45866 Kapseln
Phosphonorm, Hartkapseln
Phosphonorm, Hartkapseln
Phosphonorm, Hartkapseln
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
29/07/2022
Summary of Product Characteristics
Français
29/07/2022
Summary of Product Characteristics
Italien
29/07/2022
Patient information leaflet
Allemand
27/07/2022
Patient information leaflet
Français
27/07/2022
Patient information leaflet
Italien
27/07/2022

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
9.725 UG Substance HBESI

Reimbursement information

Public price
CHF 51.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1987

Authorization holder

Salmon Pharma GmbH

4052 Basel

Authorization information

Swissmedic authorization number
45866
Drug name
Phosphonorm, Hartkapseln
Galenic form
KAHA
ATC Code
M05BX02
Authorization status
Z
Dispensing category
B
First authorization
17/02/1984
Authorization expiration date
31/12/9999
IT Number
07.99.0.
Domain
Human medicine
Field of application
Phosphatbinder

Package details

Description (FR)
PHOSPHONORM caps 300 mg 100 pce
Description (DE)
PHOSPHONORM Kaps 300 mg 100 Stk
Market launch
17/02/1984
Narcotic (BTM)
No